Novartis Gains Approval for Groundbreaking Mala...

By Rene Pretorius

July 30, 2025

In this article we review Swissmedic's approval of Novartis' Coartem Baby. It is the first malaria treatment for infants under 4.5 kilograms. This novel formulation addresses a critical gap in antimalarial care. Existing treatments were unsuitable...
ViiV Healthcare Licensing: Expanding Access to Long-Acting HIV Treatment in L...
ARVs Water Impact: Examining the Environmental Consequences of Antiretroviral...
Lenacapavir HIV Prevention: Gilead’s Strategic Agreement to Enhance Acc...
Revolutionizing Pediatric Care: Approval of Malaria Medicine for Newborns
Private Health Funding Under South Africa’s National Health Insurance Act
Advancements in HIV Vaccine Trials: Promising Results from mRNA Strategies
HPV-Related Cancer Trends in South Africa 2011-2021
South Africa Health Reform: A Critical Examination of Universal Coverage Prop...
Publication Delays Impact Careers of Early-Career Researchers
South Africa NHI Bill Court Ruling Calls for Scrutiny
Reassuring the Private Sector on National Health Insurance South Africa: A Pa...
A Shared-Value Model for Enhancing Diabetes Care in South Africa